Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sirenko

Showing results (291-300 of 300) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 300 results.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
Journal of Hypertension|January 19, 2016
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after strokeAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.
Journal of Hypertension|July 1, 2014
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trialAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.
Journal of Hypertension|July 1, 2014
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidenceAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Blood|April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromesMaria Sirenko, Elsa Bernard, Maria Creignou, et al.
Blood|July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implicationsElsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Nature Communications|November 4, 2017
Mammalian γ2 AMPK regulates intrinsic heart rateArash Yavari, Mohamed Bellahcene, Annalisa Bucchi, et al.
European Heart Journal|June 18, 2013
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, et al.
Pageof 30

Showing results (291-300 of 300) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 300 results.
ESMO Open|March 7, 2024
Analytical validation of HER2DX genomic test for early-stage HER2-positive breast cancerM Marín-Aguilera, P Jares, E Sanfeliu, et al.
Journal of Hypertension|January 19, 2016
Continuation of the ESH-CHL-SHOT trial after publication of the SPRINT: rationale for further study on blood pressure targets of antihypertensive treatment after strokeAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.
Journal of Hypertension|July 1, 2014
Blood pressure and LDL-cholesterol targets for prevention of recurrent strokes and cognitive decline in the hypertensive patient: design of the European Society of Hypertension-Chinese Hypertension League Stroke in Hypertension Optimal Treatment randomized trialAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.
Journal of Hypertension|July 1, 2014
Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidenceAlberto Zanchetti, Lisheng Liu, Giuseppe Mancia, et al.
Ebiomedicine|December 17, 2025
Male survival disadvantage in pulmonary hypertension: independent of aetiology, age, disease severity, comorbidities and treatmentAthiththan Yogeswaran, Jeffrey S Annis, Meike Fünderich, et al.
American Journal of Hematology|June 9, 2026
Therapeutic Outcomes in VEXAS Syndrome: A Multicenter Comparative Cohort of Allogeneic Hematopoietic Stem Cell Transplantation and Hypomethylating AgentsSaubia Fathima, Margaret Mei-Kay Wong, Jesus Gonzalez-Lugo, et al.
Blood|April 30, 2024
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromesMaria Sirenko, Elsa Bernard, Maria Creignou, et al.
Blood|July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implicationsElsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.
Nature Communications|November 4, 2017
Mammalian γ2 AMPK regulates intrinsic heart rateArash Yavari, Mohamed Bellahcene, Annalisa Bucchi, et al.
European Heart Journal|June 18, 2013
2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)Giuseppe Mancia, Robert Fagard, Krzysztof Narkiewicz, et al.
Pageof 30